THE WOODLANDS, Texas, June 29 /PRNewswire/ -- The physicians of Hematology-Oncology Associates, P.C in Albuquerque, N.M., an eight provider community based specialty practice caring for adults with cancers and blood disorders, today announced they have entered into an agreement with Oncology Pharmaceutical Services (OPS) to secure its oncology drug purchasing, distribution services, and the support of an oncology-trained consultant pharmacist.
By working with OPS, a service of US Oncology, Inc., Hematology-Oncology Associates has access to a range of services focused on enhancing the performance of the practice. The services are customized to the specific needs of community-based practices and include drug management services, such as admixture training, inventory management, enhanced charge capture, regimen analysis, and admixture and clinical staff training and education.
"This type of support allows us to practice more efficiently and will help us continue to provide the excellent service and quality of care that the community has come to expect from us," said Dr. Victor Vigil, lead oncologist at Hematology-Oncology Associates.
State-of-the-art drug distribution services and network drug contracting are vital parts of the services provided by OPS to benefit the Hematology-Oncology Associates practice. As a complement to these OPS services, the consultant pharmacist is a resource who focuses on providing ongoing economic value and process improvement support to Hematology-Oncology Associates.
The relationship brings together the expertise of seven oncologists, a clinical nurse specialist, and many support staff with the knowledge of an oncology pharmacist team that share a vision of optimizing practice performance in the community setting.
About Hematology Oncology Associates, P.C.
For over 30 years, the physicians and staff at Hematology Oncology Associates of New Mexico have been providing comprehensive care for adults with cancer and blood disorders. With state-of-the-art treatment technologies, cutting-edge clinical trials research, and access to a wide array of services, the practice is devoted to providing the best possible care to its patients.
Co-founder Dr. Paul Duncan, and his colleagues Dr. Victor Vigil, Dr. Lorraine Sanchez, Dr. Malcolm Purdy, Dr. James Lin, Dr. Lovie Bey and Debra Winkeljohn, CNS, are committed to providing the people of New Mexico with the highest standard of care available. In addition, two of the group's physicians are focused on genetic screening and counseling for patients and family members with hereditary cancers. For more information, visit the company's Web site, www.hoanm.com.
About Oncology Pharmaceutical Services
Oncology Pharmaceutical Services (OPS), a service of US Oncology, Inc., includes powerful network drug contracting, state-of-the art drug distribution, and the valuable support of oncology-trained consultant pharmacists. In addition, OPS offers a variety of innovative tools and resources specially designed for the complexity of cancer care, focusing on providing economic value, clinical insight, and process improvement.
About US Oncology
US Oncology, Inc., headquartered in the Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,227 physicians operating in 468 locations, including 95 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.
|SOURCE US Oncology, Inc.|
Copyright©2009 PR Newswire.
All rights reserved